USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Evonik Oxeno GmbH & Co. KG

USPTO PatentsView assignee record - 21 granted patents across 15 technology areas, recorded in grant years 2024–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07C (Acyclic OR Carbocyclic Compounds).

RSS updates for this company

The verdict

According to USPTO PatentsView, Evonik ranks #13,977 of 49,997 tracked US assignees by granted-patent volume, with 21 patents across 15 technology areas.

#13,977
of 49,997 US assignees by volume
Top 8%
by Innovation Score (54.1/100)
16.3
avg claims per patent

USPTO PatentsView assignee plate

Corpus R13977 · Foreign Corporation #13,977 · 21 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-SMALL 21 grants
  • MID-PACK #13,977/49,997
  • PHOTO-FINISH Energy Full
  • CPC-FOCUS C07C · 15 areas
  • INNOV-PAR 54.1/100
  • CLAIMS-RICH 16.3 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • SPAN-YRS 2024–2025 · 2y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Energy Full Electronics Co., Ltd (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Evonik’s 54.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Evonik

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Evonik's Innovation Score is 54.1/100 (top 8% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Evonik?

Each dot is one of Evonik’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Evonik’s own 16.3 claims/patent is at or below the 18.9 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Evonik vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 20.920.92121.1 01020304050 Granted patents (volume) Avg claims / patent Energy Full Electronics Co., Ltd - 21, 12.48Energy FullEpiVax Inc. - 21, 12.95EpivaxErber AG - 21, 8.67ErberEtaGen, Inc. - 21, 25.29EtagenExabeam, Inc. - 21, 20ExabeamExcelitas Canada, Inc. - 21, 20.86Excelitas CanadaExegy Incorporated - 21, 40.48Exegy IncorporatedEyePoint Pharmaceuticals, Inc. - 21, 18.9Eyepoint Pharmace…Evonik Oxeno GmbH & Co. KG - 21, 16.29Evonik Oxeno & KG
Evonik vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Evonik's grants concentrate

Evonik Oxeno GmbH & Co. KG is a focused PatentsView assignee: 15 CPC subclasses with 76.2% of grants classified under C07C (Acyclic OR Carbocyclic Compounds). By volume, Evonik sits between Energy Full Electronics Co., Ltd and EyePoint Pharmaceuticals, Inc..

Evonik's three-year grant acceleration

Evonik Oxeno GmbH & Co. KG shows 14 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Evonik's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Evonik holds 21 patents at rank #13,978, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Evonik

By rank, the assignees closest to #13,978 in granted patent volume.

Leaders in C07C (Acyclic OR Carbocyclic Compounds)

Other assignees with the most granted patents in Evonik's primary technology class.

Evonik's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

54 Top 8% higher than 92% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

6810121416 20242025 7
USPTO utility patent grants by year · 2024–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2024–2019 baseline. Full figures in the table below.

View data table
Evonik Oxeno GmbH & Co. KG patent grants by year, 2015–2025
Year Patents Granted Share of Period
2024 14 66.7%
2025partial year 7 33.3%

Which technologies does Evonik Oxeno GmbH & Co. KG patent most?

Top 15 of 15 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Evonik Oxeno GmbH & Co. KG's patent record in context - here's where to go next.

  • Evonik Oxeno GmbH & Co. KG's lead technology class is C07C (Acyclic OR Carbocyclic Compounds), 76.2% of its portfolio - see every assignee active in that class. Explore C07C
  • Ranked #13,977 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Evonik Oxeno GmbH & Co. KG against Energy Full Electronics Co., Ltd, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 54.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.